Acumed Acquires ExsoMed

Acumed, a Colson Medical | Marmon | Berkshire Hathaway company, has purchased ExsoMed, a hand surgery solutions provider. Terms of the deal were not disclosed.
 
Acumed executives said the acquisition enhances the company’s portfolio of upper extremity solutions for simple to complex injuries. ExsoMed’s products support an intramedullary approach to treating hand fractures,
 
“Demand for minimally invasive surgical devices continues to grow and the ExsoMed products are great additions to our minimally invasive offerings,” said Milton Torres, vice president of Hand and Upper Extremity at Acumed. “ExsoMed’s products are a natural fit for Acumed’s portfolio of industry-first hand and wrist solutions. These products are designed to provide surgeons with in-situ customization options to achieve optimal patient fit and restoration of function.”
 
Acumed’ selection of upper extremity fixation and specialty plates will now be complemented by ExsoMed’s threaded nails, which offer minimally invasive solutions to treat fractures, fusions, and late-stage arthritic conditions.
 
ExsoMed products include:

• INnate – ExsoMed’s solution for treating metacarpal fractures. INnate is an intramedullary threaded nail designed to provide surgeons with a solution for treating metacarpal fractures through a simple, minimally invasive approach.
• InFrame – Designed specifically for phalanx fractures, providing surgeons with a reliable solution through a simple, minimally invasive approach. The robust length offering of InFrame is intended to accurately fit the intramedullary canal and achieve bicortical bone purchase, creating stable fixation and precise reduction for all types of phalanx fractures.
• ArrowPhix – ExsoMed’s arrow-shaped screw for functional variable angle DIP fusions. The related ArcPhix is an angled screw for strong, functional angle DIP fusions. Research has shown that when a patient’s distal interphalangeal joint is fused in a functional position, finger dexterity and grip strength improve over that of a patient with a straight, strength fusion.

“Patients, surgeons, and innovation have been the key drivers in all of ExsoMed’s business decisions,” said James Young Kim, chief marketing officer for ExsoMed. “The culture, history, and ambitions of Acumed align so naturally for us at ExsoMed that this decision to join the growing Acumed family was never second-guessed. We are grateful for the opportunity to expand ExsoMed’s technologies utilizing Acumed’s vast resources and continuing to raise the standard of care in hand surgery.”
 
“We are thrilled by the addition of ExsoMed to the Acumed portfolio of upper extremity, lower extremity, CMF, tendon, ligament, and orthobiologics solutions to better serve our customers worldwide,” Acumed President Hjalmar Pompe van Meerdervoort said. “With Acumed’s experience and resources, we are excited to combine efforts with ExsoMed to accelerate the shift in the standard of care for hand fractures.”